medicinal chemistry Natural Products

Preliminary Pre-Clinical Evaluation of a Molecule With Anti-Seizure Effects

BICS01 Epilepsy ASD molecule

Despite the availability of around 30 anti-seizure drugs, drug-resistant epilepsy remains a significant clinical and societal burden. We report the first promising result of a new candidate BICS01.

Planegg / Martinsried (Germany) – January 7, 2022 – Bicoll, an expert in synthesizing new and relevant small molecules as starting points for accelerated drug development, worked together with its partners at the University College London, FutureNeuro, and Royal College of Surgeons to publish data for a promising anti-seizure drug candidate BICS01 in Frontiers in Neurology.

Read more

Bicoll News 2010

Bicoll Newsletter Edition 2010 Successful preliminary results in a joint research project in drug discovery from natural products with our partner Genfit SA Modernization of our laboratory facilities with focus on medicinal chemistry New Advisory Board member for Bicoll – …

Read more

Join us at Biotechgate Partnering February 7th - 11thBiotechgate Partnering
+ +